Patents Assigned to MedTrade Products Limited
-
Publication number: 20170128270Abstract: The present invention relates to a wound dressing composition for use as or in a wound dressing and to methods of making the wound dressing composition. The wound dressing composition comprises an absorbent material, an adhesive material and an anchor material attached to the absorbent material and the adhesive material. The anchor material is operable to maintain a link between the absorbent material and the adhesive material when the wound dressing composition is wet.Type: ApplicationFiled: March 19, 2015Publication date: May 11, 2017Applicant: Medtrade Products LimitedInventors: Andrew Hoggarth, Craig Hardy
-
Patent number: 9370451Abstract: A medical device for delivery of a therapeutic agent to a physiological target site includes a flexible receptacle containing said therapeutic agent, wherein at least a part of the receptacle is formed of a water-soluble or water-dispersible material. The therapeutic agent may include a haemostatic agent and the physiological target site may be a wound.Type: GrantFiled: November 16, 2007Date of Patent: June 21, 2016Assignee: MEDTRADE PRODUCTS LIMITEDInventors: Craig Julian Hardy, Stewart Andrew Darby, Andrew Guy Eason
-
Publication number: 20150306274Abstract: The present invention relates to a haemostatic material comprising a carrier layer and a material for wound contact comprising at least one haemostat in particulate, granular, powder, flake or short fibrous form. Such a haemostatic material is useful, for example, in reducing or stopping bleeding of a physiological target site in a person or animal, and can also be used to stem bleeding during medical procedures.Type: ApplicationFiled: May 22, 2015Publication date: October 29, 2015Applicant: MEDTRADE PRODUCTS LIMITEDInventors: Craig Julian Hardy, Andrew Darby, Guy Eason
-
Publication number: 20140162977Abstract: An anti-microbial absorbent chitosan, optionally in the form or fibres, derivatised by treatment with high energy, in particular gamma, radiation, a non-woven fabric and an absorbent device comprising the derivatised chitosan, methods for the preparation of such a chitosan, non-woven fabric and an absorbent device, and the use of said absorbent device in wound care.Type: ApplicationFiled: May 10, 2012Publication date: June 12, 2014Applicant: Medtrade Products LimitedInventor: Christian Stephenson
-
Publication number: 20140105950Abstract: The present invention relates to a haemostatic material comprising a haemostat agent and a bioadhesive agent. Such a haemostatic material is useful, for example, in effectively controlling bleeding with a reduced compression period compared to the guidance of a minimum of three minutes compression using a haemostatic bandage.Type: ApplicationFiled: March 12, 2012Publication date: April 17, 2014Applicant: MEDTRADE PRODUCTS LIMITEDInventors: Craig Hardv, Guy Eason, Andrew Hoggarth
-
Patent number: 8106030Abstract: A hemostatic powder comprises a chitosan salt together with at least one inert material. The disclosure also relates to hemostatic powders into which fluid penetrability is 0.5 cm or more within 1 minute. At least one medical surfactant may optionally be included. The hemostatic powders may be incorporated into wound dressings.Type: GrantFiled: December 19, 2006Date of Patent: January 31, 2012Assignee: Medtrade Products LimitedInventors: Craig Hardy, Edwin Lee Johnson, Paul Luksch
-
Patent number: 8039449Abstract: A hemostatic powder comprises a chitosan salt together with at least one inert material. The disclosure also relates to hemostatic powders into which fluid penetrability is 0.5 cm or more within 1 minute. At least one medical surfactant may optionally be included. The hemostatic powders may be incorporated into wound dressings.Type: GrantFiled: December 19, 2006Date of Patent: October 18, 2011Assignee: Medtrade Products LimitedInventors: Craig Hardy, Edwin Lee Johnson, Paul Luksch
-
Publication number: 20110236433Abstract: An absorbent wound care device includes two or more materials which individually do not gel when exposed to a fluid but do gel when brought together and exposed to a fluid. The device is particularly intended for haemostatic use and for absorbing bodily fluids being emitted from wounds and physiological target sites.Type: ApplicationFiled: September 14, 2009Publication date: September 29, 2011Applicant: MEDTRADE PRODUCTS LIMITEDInventors: Craig Hardy, Stewart Andrew Darby
-
Patent number: 7981872Abstract: A hemostatic powder comprises a chitosan salt together with at least one medical surfactant. At least one inert material may optionally be included. The hemostatic powder may be incorporated into wound dressings.Type: GrantFiled: December 19, 2006Date of Patent: July 19, 2011Assignee: Medtrade Products LimitedInventors: Craig Hardy, Edwin Lee Johnson, Paul Luksch
-
Publication number: 20100092525Abstract: A medical device for delivery of a therapeutic agent to a physiological target site includes a flexible receptacle containing said therapeutic agent, wherein at least a part of the receptacle is formed of a water-soluble or water-dispersible material. The therapeutic agent may include a haemostatic agent and the physiological target site may be a wound.Type: ApplicationFiled: November 16, 2007Publication date: April 15, 2010Applicant: MEDTRADE PRODUCTS LIMITEDInventors: Craig Julian Hardy, Stewart Andrew Darby, Andrew Guy Eason
-
Publication number: 20090186851Abstract: A hemostatic powder comprises a chitosan salt together with at least one inert material. The disclosure also relates to hemostatic powders into which fluid penetrability is 0.5 cm or more within 1 minute. At least one medical surfactant may optionally be included. The hemostatic powders may be incorporated into wound dressings.Type: ApplicationFiled: December 19, 2006Publication date: July 23, 2009Applicant: MEDTRADE PRODUCTS LIMITEDInventors: Craig Hardy, Edwin Lee Johnson, Paul Luksch
-
Publication number: 20090149422Abstract: A hemostatic powder comprises a chitosan salt together with at least one medical surfactant. At least one inert material may optionally be included. The hemostatic powder may be incorporated into wound dressings.Type: ApplicationFiled: December 19, 2006Publication date: June 11, 2009Applicant: MEDTRADE PRODUCTS LIMITEDInventors: Craig Hardy, Edwin Lee Johnson, Paul Luksch
-
Publication number: 20050143345Abstract: A scar management composition for reducing the cosmetic severity of scars which comprises at least one silicone component, water and at least one thickening agent.Type: ApplicationFiled: December 13, 2002Publication date: June 30, 2005Applicant: MEDTRADE PRODUCTS LIMITEDInventor: Craig Hardy
-
Patent number: D531495Type: GrantFiled: July 18, 2005Date of Patent: November 7, 2006Assignee: MedTrade Products LimitedInventors: Craig Julian Hardy, Andrew Darby